Padcev-Keytruda Combo Lands Another Win in Bladder Cancer

By News Health
2 hours Ago

(MedPage Today) — SAN FRANCISCO — Perioperative treatment with enfortumab vedotin (Padcev) plus pembrolizumab (Keytruda) significantly improved survival compared with standard neoadjuvant chemotherapy in patients with muscle-invasive bladder…

Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/120087

Author :

Publish date : 2026-02-27 20:11:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Early Bleeding Alone Not Tied to Pregnancy Loss Risk

FDA Approves Desmoda for Central Diabetes Insipidus

Casey Means' Cringey Senate Hearing Should Sink Her Surgeon General Bid

Exercise May Up QoL When Taking Chemo for Breast Cancer

AI Vulnerable to Fake Info; Vegetarians Have Fewer Cancers; 'Snooki' Has Cancer

Study Warns of Large Increase in New HIV Cases in U.S. if Ryan White Program Ends